Juliane Lubitz

Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.

M. Rezai, C. Denkert, J. Heil, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

J. Heil, S. Kuemmel, J. Blohmer, 2020, Annals of surgery.

Prospective, multicenter registry trial to evaluate the clinical feasibility of targeted axillary dissection (TAD) in patients (pts) with breast cancer (BC) and core biopsy proven axillary involvement (cN+)

J. Heil, S. Kuemmel, V. Hanf, 2019, Annals of Oncology.

Randomized surgical multicenter trial to evaluate the usefulness of lymphoscintigraphy (LSG) prior to sentinel node biopsy (SLNB) in early breast cancer: SenSzi (GBG80) trial.

M. Rezai, C. Denkert, J. Heil, 2017 .